Relapsed/refractory NUP98-R acute leukemia

Clinical trials for Relapsed/refractory NUP98-R acute leukemia explained in plain language.

Never miss a new study

Get alerted when new Relapsed/refractory NUP98-R acute leukemia trials appear

Sign up with your email to follow new studies for Relapsed/refractory NUP98-R acute leukemia, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

New hope for kids with tough leukemia: targeted drug combo enters first human trial

Disease control Recruiting now

This early-phase trial tests a new drug called ziftomenib, taken as a capsule, together with standard chemotherapy (cytarabine and fludarabine) for children and young adults up to age 21 who have a relapsed or refractory acute leukemia with specific genetic changes (KMT2A-r, NUP9…

Matched conditions: RELAPSED/REFRACTORY NUP98-R ACUTE LEUKEMIA

Phase 1 • Sponsor: PedAL BCU, LLC • Aim: Disease control

Last updated Jun 27, 2026 07:55 UTC

Relapsed/refractory NUP98-R acute leukemia

Get alerted when new Relapsed/refractory NUP98-R acute leukemia trials appear

New hope for kids with tough leukemia: targeted drug combo enters first human trial